F protein-subunit based vaccines, adjuvants & potency Both prefusion and postfusion F protein vaccines are being tested in clinical trials. Previous studies showed that alum had a modest effect on ...

A subunit vaccine makes use of just a small portion of a pathogen. For a virus, the vaccine can contain just a piece of the protein coat that surrounds the virus's DNA (or RNA). Even small portion ...

Calder also plans to apply its technology more generally in protein engineering, imparting thermostability as needed to additional subunit vaccines, biologics, or other targets. The work is ...

Currently, there are two types of COVID-19 vaccines for use in the United States: mRNA vaccines and protein subunit vaccines. All COVID-19 vaccines provide protection from the virus that causes ...

Based on these findings, Berenson speculated that the presence of spike proteins may suggest that the "genetic material" of the mRNA vaccines may have contaminated human DNA. However, he said that ...

pseudomallei. Research in the Burtnick lab is currently focused on the development of melioidosis subunit vaccines that include a combination of polysaccharides and proteins. In collaboration with the ...

The study reported that subsequent subunit vaccines targeted glycoprotein B, a key viral entry protein. These vaccines demonstrated modest efficacy, with phase II trials showing approximately 50% ...

The goal of these vaccines is to use a gene from a pathogen to generate an immune response. A gene contains the instructions to create a protein. With a genetic vaccine, small loops of DNA in the ...